Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway
- PMID: 17582000
- PMCID: PMC1951437
- DOI: 10.1128/JVI.00537-07
Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway
Abstract
Epstein-Barr virus (EBV) latent membrane protein 2A (LMP2A) is widely expressed in EBV-infected cells within the infected human host and EBV-associated malignancies, suggesting that LMP2A is important for EBV latency, persistence, and EBV-associated tumorigenesis. Previously, we demonstrated that LMP2A provides an antiapoptotic signal through the activation of phosphatidylinositol 3-kinase (PI3-K)/Akt pathway in vitro. However, the exact function of LMP2A in tumor progression is not well understood. In this study, we found that LMP2A did not induce anchorage-independent cell growth in a human keratinocyte cell line, HaCaT, but did in a human gastric carcinoma cell line, HSC-39. In addition, LMP2A activated the PI3-K/Akt pathway in both HaCaT and HSC-39 cells; however, LMP2A did not activate Ras in HaCaT cells but did in HSC-39 cells. Furthermore, the Ras inhibitors manumycin A and a dominant-negative form of Ras (RasN17) and the PI3-K inhibitor LY294002 blocked LMP2A-mediated Akt phosphorylation and anchorage-independent cell growth in HSC-39 cells. These results suggest that constitutive activation of the Ras/PI3-K/Akt pathway by LMP2A is a key factor for LMP2A-mediated transformation.
Figures






Similar articles
-
Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.Oncogene. 2004 Nov 11;23(53):8619-28. doi: 10.1038/sj.onc.1207905. Oncogene. 2004. PMID: 15361852
-
Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.J Virol. 2000 Nov;74(22):10681-9. doi: 10.1128/jvi.74.22.10681-10689.2000. J Virol. 2000. PMID: 11044112 Free PMC article.
-
Epstein-Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3-kinase/Akt pathway.Electrophoresis. 2008 Aug;29(15):3192-200. doi: 10.1002/elps.200800086. Electrophoresis. 2008. PMID: 18604870
-
The signaling pathways of Epstein-Barr virus-encoded latent membrane protein 2A (LMP2A) in latency and cancer.Cell Mol Biol Lett. 2009;14(2):222-47. doi: 10.2478/s11658-008-0045-2. Epub 2008 Dec 13. Cell Mol Biol Lett. 2009. PMID: 19082921 Free PMC article. Review.
-
Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Infect Agents Dis. 1994. PMID: 7812651 Review.
Cited by
-
Kinases and therapeutics in pathogen mediated gastric cancer.Mol Biol Rep. 2022 Mar;49(3):2519-2530. doi: 10.1007/s11033-021-07063-9. Epub 2022 Jan 15. Mol Biol Rep. 2022. PMID: 35031925 Review.
-
Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.PLoS One. 2014 Aug 15;9(8):e105163. doi: 10.1371/journal.pone.0105163. eCollection 2014. PLoS One. 2014. PMID: 25126743 Free PMC article.
-
Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma.PLoS Pathog. 2010 Jun 3;6(6):e1000940. doi: 10.1371/journal.ppat.1000940. PLoS Pathog. 2010. PMID: 20532215 Free PMC article.
-
Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma.Cancer Sci. 2008 Sep;99(9):1726-33. doi: 10.1111/j.1349-7006.2008.00888.x. Epub 2008 Jul 4. Cancer Sci. 2008. PMID: 18616681 Free PMC article. Review.
-
EBV LMP2A affects LMP1-mediated NF-kappaB signaling and survival of lymphoma cells by regulating TRAF2 expression.Blood. 2008 Apr 1;111(7):3813-20. doi: 10.1182/blood-2007-03-080309. Epub 2008 Jan 29. Blood. 2008. PMID: 18230756 Free PMC article.
References
-
- Barbacid, M. 1987. ras genes. Annu. Rev. Biochem. 56:779-827. - PubMed
-
- Bell, A. I., K. Groves, G. L. Kelly, D. Croom-Carter, E. Hui, A. T. Chan, and A. B. Rickinson. 2006. Analysis of Epstein-Barr virus latent gene expression in endemic Burkitt's lymphoma and nasopharyngeal carcinoma tumour cells by using quantitative real-time PCR assays. J. Gen. Virol. 87:2885-2890. - PubMed
-
- Boukamp, P., E. J. Stanbridge, D. Y. Foo, P. A. Cerutti, and N. E. Fusenig. 1990. c-Ha-ras oncogene expression in immortalized human keratinocytes (HaCaT) alters growth potential in vivo but lacks correlation with malignancy. Cancer Res. 50:2840-2847. - PubMed
-
- Breitkreutz, D., P. Boukamp, C. M. Ryle, H. J. Stark, D. R. Roop, and N. E. Fusenig. 1991. Epidermal morphogenesis and keratin expression in c-Ha-ras-transfected tumorigenic clones of the human HaCaT cell line. Cancer Res. 51:4402-4409. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources